Biocartis, Fast-track eye 2017 launch of respiratory infection panel for Idylla
This article was originally published in Clinica
Executive Summary
Biocartis is partnering with Fast-track diagnostics to develop syndromic multiplex tests that will run on Biocartis’ Idylla analyzer and the first assay is expected to be ready two years from now.
You may also be interested in...
Siemens Adds Infectious Disease Tests With Luxembourg's Fast-Track Diagnostics
Siemens Healthineers has signed an agreement to acquire Luxembourg-based Fast Track Diagnostics (FTD) the developer of diagnostics that can distinguish between viral, bacterial, or other infections in one test. The deal comes as Siemens is shaping up to float Healthineers, as an independently publicly-listed company.
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.